The following is a list of the top 100 prescribed medicines by US National Sales in Q2 2011. Figures include sales through both retail and hospital channels, listed by drug name and units sold in the United States.
| Rank |
Drug |
Units (000) |
|
|
1 ( ) |
acetaminophen/hydrocodone
Generic |
9,592 |
 |
Stats |
2 ( 1) |
Nexium
AstraZeneca Pharmaceuticals |
7,476 |
-0.77% |
Stats |
| 3 (3) |
Singulair
Merck & Co., Inc. |
7,442 |
6.34% |
Stats |
4 ( 2) |
budesonide
Generic |
7,220 |
-29.37% |
Stats |
| 5 |
One Touch Ultra
|
7,145 |
0.45% |
Stats |
| 6 (2) |
ProAir HFA
Teva Pharmaceuticals |
7,070 |
-2.92% |
Stats |
| 7 |
Lipitor
Pfizer Inc |
6,492 |
1.93% |
Stats |
| 8 |
Advair Diskus
GlaxoSmithKline |
6,094 |
-2.93% |
Stats |
| 9 |
Lantus
Sanofi-Aventis |
6,056 |
-2.51% |
Stats |
| 10 |
Cymbalta
Eli Lilly and Company |
5,949 |
4.46% |
Stats |
| 11 |
Plavix
Bristol-Myers Squibb Company |
5,459 |
-0.18% |
Stats |
| 12 |
fentanyl
Generic |
4,569 |
4.58% |
Stats |
| 13 (12) |
AndroGel
Abbott Laboratories |
4,504 |
93.39% |
Stats |
| 14 (1) |
Crestor
AstraZeneca Pharmaceuticals |
3,915 |
3.35% |
Stats |
| 15 |
Spiriva
Boehringer Ingelheim Pharmaceuticals, Inc |
3,219 |
2.29% |
Stats |
| 16 (1) |
venlafaxine
Generic |
3,137 |
6.48% |
Stats |
| 17 (3) |
Actos
Takeda Pharmaceuticals North America, Inc |
3,109 |
-4.89% |
Stats |
| 18 (1) |
Lantus Solostar
Sanofi-Aventis |
3,068 |
8.30% |
Stats |
| 19 (3) |
Novolog
Novo Nordisk Inc. |
2,966 |
-0.70% |
Stats |
| 20 (2) |
Nasonex
Merck & Co., Inc. |
2,954 |
0.75% |
Stats |
| 21 (1) |
Humalog
Eli Lilly and Company |
2,647 |
1.15% |
Stats |
| 22 |
Abilify
Otsuka Pharmaceutical Co. |
2,564 |
0.98% |
Stats |
| 23 () |
Synthroid
Abbott Laboratories |
2,544 |
|
Stats |
| 24 (1) |
metoprolol
Generic |
2,526 |
4.38% |
Stats |
| 25 (11) |
Levemir
Novo Nordisk Inc. |
2,316 |
23.65% |
Stats |
| 26 (2) |
Lexapro
Forest Pharmaceuticals, Inc |
2,314 |
-0.94% |
Stats |
| 27 (1) |
Diovan
Novartis Corporation |
2,298 |
-1.03% |
Stats |
| 28 (1) |
valacyclovir
Generic |
2,248 |
5.84% |
Stats |
| 29 (1) |
Combivent
Boehringer Ingelheim Pharmaceuticals, Inc |
2,108 |
-2.86% |
Stats |
| 30 |
Namenda
Forest Pharmaceuticals, Inc |
2,073 |
-0.86% |
Stats |
| 31 |
Lyrica
Pfizer Inc |
2,050 |
0.74% |
Stats |
| 32 (1) |
Januvia
Merck & Co., Inc. |
2,028 |
3.89% |
Stats |
| 33 (1) |
Zetia
Merck & Co., Inc. |
2,027 |
-0.10% |
Stats |
| 34 |
bupropion
Generic |
2,025 |
4.60% |
Stats |
| 35 (9) |
NovoLog FlexPen
Novo Nordisk Inc. |
1,953 |
29.60% |
Stats |
| 36 (1) |
Seroquel
AstraZeneca Pharmaceuticals |
1,832 |
-0.54% |
Stats |
| 37 (2) |
Flovent HFA
GlaxoSmithKline |
1,826 |
-4.60% |
Stats |
| 38 (1) |
donepezil
Generic |
1,804 |
3.50% |
Stats |
| 39 (1) |
Suboxone
Reckitt Benckiser Pharmaceuticals Inc. |
1,736 |
4.08% |
Stats |
| 40 (2) |
Lovaza
GlaxoSmithKline |
1,715 |
4.00% |
Stats |
| 41 (3) |
Vytorin
Merck & Co., Inc. |
1,698 |
-7.52% |
Stats |
| 42 (1) |
Benicar
Daiichi Sankyo |
1,606 |
-2.96% |
Stats |
| 43 |
Lidoderm
Endo Pharmaceuticals |
1,599 |
-0.19% |
Stats |
| 44 (5) |
Remicade
Centocor Ortho Biotech, Inc |
1,552 |
7.11% |
Stats |
| 45 (6) |
enoxaparin
Generic |
1,518 |
10.80% |
Stats |
| 46 |
Symbicort
AstraZeneca Pharmaceuticals |
1,486 |
0.41% |
Stats |
| 47 (2) |
Zyprexa
Eli Lilly and Company |
1,473 |
-1.14% |
Stats |
| 48 (1) |
Diovan HCT
Novartis Corporation |
1,431 |
-2.12% |
Stats |
| 49 (1) |
OxyContin
|
1,365 |
-1.02% |
Stats |
| 50 (2) |
Restasis
Allergan, Inc |
1,297 |
0.23% |
Stats |
| 51 (2) |
Niaspan
Abbott Laboratories |
1,262 |
-1.02% |
Stats |
| 52 (4) |
Lovenox
Sanofi-Aventis |
1,233 |
-15.37% |
Stats |
| 53 (2) |
Celebrex
Pfizer Inc |
1,064 |
2.01% |
Stats |
| 54 (2) |
TriCor
Abbott Laboratories |
1,003 |
-1.86% |
Stats |
| 55 (2) |
Evista
Eli Lilly and Company |
965 |
-3.50% |
Stats |
| 56 () |
VESIcare
Astellas Pharma US |
952 |
|
Stats |
| 57 (1) |
Aciphex
Eisai Corporation |
947 |
-4.63% |
Stats |
| 58 (2) |
Enbrel
Amgen Inc. |
874 |
3.19% |
Stats |
| 59 |
Detrol LA
Pfizer Inc |
857 |
-7.65% |
Stats |
| 60 (1) |
Janumet
Merck & Co., Inc. |
855 |
3.14% |
Stats |
| 61 (2) |
Epogen
Amgen Inc. |
793 |
4.48% |
Stats |
| 62 (2) |
Geodon
Pfizer Inc |
739 |
-0.27% |
Stats |
| 63 (2) |
Vyvanse
Shire US Inc |
661 |
-1.49% |
Stats |
| 64 (3) |
Rebif
|
605 |
-0.66% |
Stats |
| 65 (3) |
amphetamine/dextroamphetamine
Generic |
577 |
7.25% |
Stats |
| 66 (3) |
Cialis
Eli Lilly and Company |
547 |
2.43% |
Stats |
| 67 (5) |
Rituxan
Genentech, Inc |
537 |
5.09% |
Stats |
| 68 (2) |
Truvada
Gilead Sciences, Inc. |
534 |
1.71% |
Stats |
| 69 (2) |
Humira
Abbott Laboratories |
532 |
2.31% |
Stats |
| 70 (10) |
Provigil
Cephalon, Inc. |
516 |
34.73% |
Stats |
| 71 (9) |
Concerta
|
489 |
-37.94% |
Stats |
| 72 (2) |
Avastin
Genentech, Inc |
471 |
-0.63% |
Stats |
| 73 |
Viagra
Pfizer Inc |
467 |
-2.30% |
Stats |
| 74 (2) |
Seroquel XR
AstraZeneca Pharmaceuticals |
459 |
3.85% |
Stats |
| 75 |
Atripla
Gilead Sciences, Inc. |
456 |
1.79% |
Stats |
| 76 (1) |
Adderall XR
Shire US Inc |
437 |
2.58% |
Stats |
| 77 () |
methylphenidate
Generic |
421 |
|
Stats |
| 78 (4) |
Procrit
Janssen Pharmaceuticals, Inc |
380 |
5.56% |
Stats |
| 79 |
Lunesta
Sunovion Pharmaceuticals Inc. |
377 |
-2.58% |
Stats |
| 80 (1) |
Aranesp
Amgen Inc. |
372 |
-1.33% |
Stats |
| 81 (15) |
Levaquin
Ortho-McNeil-Janssen Pharmaceuticals, Inc. |
361 |
-42.24% |
Stats |
| 82 (2) |
Neulasta
Amgen Inc. |
334 |
3.41% |
Stats |
| 83 () |
Varivax
Merck & Co., Inc. |
292 |
|
Stats |
| 84 (1) |
Reyataz
Bristol-Myers Squibb Company |
285 |
1.79% |
Stats |
| 85 (1) |
Solodyn
Medicis Pharmaceutical Corporation |
267 |
-2.20% |
Stats |
| 86 () |
docetaxel
Generic |
266 |
|
Stats |
| 87 (1) |
Erbitux
Bristol-Myers Squibb Company |
259 |
-0.38% |
Stats |
| 88 (3) |
Lucentis
Genentech, Inc |
230 |
1.32% |
Stats |
| 89 (1) |
Copaxone
Teva Pharmaceuticals |
228 |
|
Stats |
| 90 (3) |
Isentress
Merck & Co., Inc. |
219 |
7.88% |
Stats |
| 91 (1) |
Zometa
|
209 |
-6.70% |
Stats |
| 92 () |
Eloxatin
Sanofi-Aventis |
182 |
|
Stats |
| 93 (2) |
Alimta
Eli Lilly and Company |
170 |
4.29% |
Stats |
| 94 (2) |
Neupogen
Amgen Inc. |
157 |
0.64% |
Stats |
| 95 (1) |
Zyvox
Pfizer Inc |
155 |
-6.06% |
Stats |
| 96 (1) |
Herceptin
Genentech, Inc |
149 |
1.36% |
Stats |
| 97 (1) |
Avonex
Biogen Idec |
140 |
-1.41% |
Stats |
| 98 () |
Velcade
Takeda Pharmaceuticals North America, Inc |
134 |
|
Stats |
| 99 (1) |
Gleevec
Novartis Corporation |
85 |
1.19% |
Stats |
| 100 (1) |
Betaseron
Bayer Healthcare Pharmaceuticals |
81 |
-7.95% |
Stats |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
)
1)
2)